CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 75 filers reported holding CARA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,923 | -71.6% | 11,329 | 0.0% | 0.00% | – |
| Q1 2024 | $10,309 | +22.5% | 11,329 | 0.0% | 0.00% | – |
| Q4 2023 | $8,418 | -55.8% | 11,329 | 0.0% | 0.00% | – |
| Q3 2023 | $19,033 | -74.4% | 11,329 | -56.9% | 0.00% | – |
| Q2 2023 | $74,432 | +1.2% | 26,301 | +75.6% | 0.00% | – |
| Q1 2023 | $73,537 | -55.3% | 14,977 | -2.1% | 0.00% | – |
| Q4 2022 | $164,354 | +14.9% | 15,303 | +0.1% | 0.00% | – |
| Q3 2022 | $143,000 | +2.9% | 15,288 | +0.8% | 0.00% | – |
| Q2 2022 | $139,000 | -46.7% | 15,162 | -29.4% | 0.00% | – |
| Q1 2022 | $261,000 | -96.5% | 21,490 | -96.2% | 0.00% | -100.0% |
| Q1 2020 | $7,435,000 | -18.0% | 562,800 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $9,067,000 | -13.7% | 562,800 | -2.1% | 0.01% | -16.7% |
| Q3 2019 | $10,504,000 | +8.4% | 574,600 | +27.5% | 0.01% | +20.0% |
| Q2 2019 | $9,686,000 | +9.6% | 450,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $8,839,000 | +50.9% | 450,500 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $5,857,000 | -45.7% | 450,500 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $10,789,000 | +25.1% | 450,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $8,627,000 | +54.7% | 450,500 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $5,577,000 | +1.1% | 450,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,514,000 | -7.3% | 450,500 | +3.7% | 0.00% | 0.0% |
| Q3 2017 | $5,948,000 | -11.1% | 434,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,687,000 | -38.6% | 434,500 | -26.6% | 0.00% | -50.0% |
| Q1 2017 | $10,892,000 | +98.0% | 592,300 | 0.0% | 0.01% | +100.0% |
| Q4 2016 | $5,502,000 | +7.8% | 592,300 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $5,105,000 | +73.6% | 611,400 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,941,000 | -22.7% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,803,000 | -63.1% | 611,400 | 0.0% | 0.00% | -60.0% |
| Q4 2015 | $10,308,000 | +18.0% | 611,400 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $8,737,000 | +17.6% | 611,400 | 0.0% | 0.00% | +33.3% |
| Q2 2015 | $7,429,000 | +20.9% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,145,000 | +0.8% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $6,096,000 | +18.8% | 611,400 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $5,130,000 | -54.9% | 611,400 | -8.6% | 0.00% | -60.0% |
| Q2 2014 | $11,380,000 | -5.6% | 668,600 | +3.2% | 0.01% | -16.7% |
| Q1 2014 | $12,061,000 | – | 648,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
| Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
| Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
| Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
| PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |